Skip to main content
H.R. 4764 116th Congress House

TRANSPLANT Act of 2020

Official title: To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.

Introduced: October 18, 2019 Introduced by: Doris O. Matsui Democratic · California See on congress.gov
Health Advisory bodiesBlood and blood diseasesCell biology and embryologyCongressional oversight
More subjectsShow fewer subjects
Government studies and investigationsHealth programs administration and fundingMedical researchOrgan and tissue donation and transplantationResearch administration and funding
Sign in to write a letter

Free account. One morning email at most, only on days something moved. Already have one? Sign in.

This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 19 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 14, 2020
Message on Senate action sent to the House.
Dec 11, 2020
Passed Senate with an amendment by Voice Vote. (text of amendment in the nature of a substitute: CR S7450-7451)
Dec 11, 2020
Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote.(text of amendment in the nature of a substitute: CR S7450-7451)
Dec 11, 2020
Measure laid before Senate by unanimous consent. (consideration: CR S7450-7451)
Oct 1, 2020
Received in the Senate, read twice.
Sep 30, 2020
Motion to reconsider laid on the table Agreed to without objection.
Sep 30, 2020
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 414 - 0 (Roll no. 211). (text: CR 09/29/2020 H4996)
Sep 30, 2020
Considered as unfinished business. (consideration: CR H5089-5090)
Sep 29, 2020
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Sep 29, 2020
DEBATE - The House proceeded with forty minutes of debate on H.R. 4764.
Sep 29, 2020
Considered under suspension of the rules. (consideration: CR H4996-4998)
Sep 29, 2020
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Sep 29, 2020
Placed on the Union Calendar, Calendar No. 449.
Sep 29, 2020
Reported by the Committee on Energy and Commerce. H. Rept. 116-549.
Sep 9, 2020
Ordered to be Reported by Voice Vote.
Sep 9, 2020
Committee Consideration and Mark-up Session Held.
Oct 21, 2019
Referred to the Subcommittee on Health.
Oct 18, 2019
Referred to the House Committee on Energy and Commerce.
Oct 18, 2019
Introduced in House
 Votes taken on this bill 1
DateChamberWhat was voted onResultYes–No
Sep 30, 2020 House · vote #211 On Motion to Suspend the Rules and Pass, as Amended Passed 414–0 See who voted →
 Amendments to this bill 1

Amendments propose changes to this bill. Members vote on amendments separately before the final bill vote. An agreed amendment becomes part of the bill; a failed amendment does not.

1 agreed to

AmendmentSponsorPurposeStatusLatest action
SAMDT 2,704 – In the nature of a substitute. Agreed to Dec 11, 2020
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action December 14, 2020

Message on Senate action sent to the House.

 Plain-English summary Congressional Research Service

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020 or the TRANSPLANT Act of 2020

This bill modifies and reauthorizes through FY2025 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also requires research and other activities related to stem cell therapies.

Specifically, the Department of Health and Human Services must conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments, and the National Institutes of Health must continue efforts to further the field of regenerative medicine using adult stem cells.

In addition, the Government Accountability Office must examine various issues related to the regenerative medicine workforce.

 Related & companion bills 2
  • HR 3520 Stem Cell Therapeutic and Research Reauthorization Act of 2019
  • S 4672 TRANSPLANT Act of 2020
 Bill text 5 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 52
All 52 Democratic 23 Republican 9
Murphy, Stephanie
· Sep 29, 2020
 D
Smith, Adam
Washington · Sep 17, 2020
 D
Brownley, Julia
California · Sep 11, 2020
 R
Emmer, Tom
Minnesota · Sep 11, 2020
 D
Hayes, Jahana
Connecticut · Sep 11, 2020
 D
Johnson, Henry C. "Hank"
Georgia · Sep 11, 2020
 R
Wagner, Ann
Missouri · Sep 11, 2020
 D
Gottheimer, Josh
New Jersey · Aug 28, 2020
 D
Case, Ed
Hawaii · Aug 14, 2020
Napolitano, Grace
· Aug 14, 2020
 D
Dean, Madeleine
Pennsylvania · Jul 29, 2020
 D
Craig, Angie
Minnesota · Jul 27, 2020
 D
McCollum, Betty
Minnesota · Jul 27, 2020
 D
Suozzi, Thomas R.
New York · Jul 27, 2020
Heck, Denny
· Jul 22, 2020
Trone, David
· Jul 22, 2020
 D
Omar, Ilhan
Minnesota · Jul 21, 2020
 D
Panetta, Jimmy
California · Jul 16, 2020
Rodgers, Cathy
· Jul 16, 2020
 D
Stanton, Greg
Arizona · Jul 16, 2020
 R
Tiffany, Thomas P.
Wisconsin · Jul 16, 2020
 D
Beatty, Joyce
Ohio · Jul 13, 2020
 D
Aguilar, Pete
California · Jul 1, 2020
 R
Waltz, Michael
Florida · May 22, 2020
 R
Hudson, Richard
North Carolina · Mar 13, 2020
 D
McGovern, James P.
Massachusetts · Mar 13, 2020
 D
Sewell, Terri A.
Alabama · Mar 13, 2020
 D
Grijalva, Raúl M.
Arizona · Feb 28, 2020
Cartwright, Matt
· Feb 26, 2020
Axne, Cynthia
· Feb 18, 2020
 D
DeGette, Diana
Colorado · Feb 13, 2020
 D
Casten, Sean
Illinois · Feb 7, 2020
 D
Harder, Josh
California · Feb 5, 2020
RUSH, BOBBY
· Feb 5, 2020
Schrader, Kurt
· Feb 4, 2020
Lowenthal, Alan
· Jan 16, 2020
Crist, Charlie
· Dec 19, 2019
Butterfield, G. K.
· Dec 17, 2019
Rouda, Harley
· Dec 4, 2019
Brown, Anthony
· Dec 3, 2019
 D
Welch, Peter
Vermont · Dec 3, 2019
YOUNG, DON
· Nov 20, 2019
 D
Neguse, Joe
Colorado · Nov 19, 2019
HASTINGS, ALCEE
· Nov 12, 2019
 D
Swalwell, Eric
California · Nov 12, 2019
 R
Aderholt, Robert B.
Alabama · Oct 28, 2019
WALDEN, GREG
· Oct 28, 2019
 R
Budd, Ted
North Carolina · Oct 23, 2019
Jackson Lee, Sheila
· Oct 23, 2019
 R
Fitzpatrick, Brian K.
Pennsylvania · Oct 22, 2019
Page 1 of 2 Next
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4764: TRANSPLANT Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-HR-4764/
MLA
"H.R. 4764: TRANSPLANT Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-4764/.
Bluebook (legal)
H.R. 4764, 116th Cong. (2026), https://openamerica.io/bill/116-HR-4764/.
Markdown link
[H.R. 4764: TRANSPLANT Act of 2020](https://openamerica.io/bill/116-HR-4764/)
Report a problem